首页> Experimental dermatology> Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort study.

Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort study.

导出原文传递

翻译打印收藏纠错

第一作者： A,Flora

第一单位： Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.;Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, New South Wales, Australia.;University of New South Wales, Sydney, New South Wales, Australia.

作者： A,Flora ^[1] ; E K,Kozera ^[2] ; R,Jepsen ^[3] ; K,Gill ^[4] ; J,Xu ^[4] ; J W,Frew ^[5]

作者单位： Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.;Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, New South Wales, Australia.;University of New South Wales, Sydney, New South Wales, Australia. ^[1] Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.;Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, New South Wales, Australia. ^[2] Holdsworth House Medical Practice, Sydney, New South Wales, Australia. ^[3] University of New South Wales, Sydney, New South Wales, Australia. ^[4] Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.;Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, New South Wales, Australia.;University of New South Wales, Sydney, New South Wales, Australia.;Holdsworth House Medical Practice, Sydney, New South Wales, Australia. ^[5]

关键词 hidradenitis suppurativa hormones inflammation interleukin-23 monocytes testosterone

医学主题词人类(Humans);男(雄)性(Male);化脓性汗腺炎(Hidradenitis Suppurativa);前瞻性研究(Prospective Studies);白细胞介素23(Interleukin-23);卵泡刺激素(Follicle Stimulating Hormone)

DOI 10.1111/exd.14789

PMID 36933897

发布时间 2023-06-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交